FDA Approves Zevaskyn for Rare, Genetic Skin Disorder
Zevaskyn is the first and only autologous cell-based gene therapy for recessive dystrophic epidermolysis bullosa
FDA Approves Dupixent for Chronic Spontaneous Urticaria
Approval granted for adults and children 12 years and older who remain symptomatic despite antihistamine treatment
Early-Onset Pediatric Atopic Dermatitis Tied to Higher Risk for Uveitis
Findings independent of autoimmune conditions or dupilumab use
Circulating Tumor DNA Can ID Outcomes for Patients With Melanoma
ctDNA detection at baseline was associated with worse recurrence-free, overall survival in BRAFV600-mutant stage III melanoma
Flares Occur Frequently in Generalized Pustular Psoriasis
Frequent treatment alterations of off-label biologics and nonsteroidal systemic agents observed
Narrowband UVB Phototherapy Underused for Pediatric Vitiligo
One-third report they were not offered the treatment option
Rates of Dissatisfaction High for Hidradenitis Suppurativa Care
74 percent of respondents unaware of FDA-approved treatments; 56 percent said these options had not been discussed by clinician
Common Photosensitizing Drugs Increase Skin Cancer Risk
Estrogen treatment increased the risk for all investigated skin cancers
NIH Ends Funding for the Effects of Climate Change on Health
Adding 3D Total Body Photography to Usual Care Increases Rate of Skin Excisions
Adding 3D TBP, sequential digital dermoscopy imaging to usual care increases skin excisions in patients at high risk for melanoma
